Royal Bank of Canada’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$31.3M Buy
109,068
+43,279
+66% +$12.4M 0.01% 1098
2025
Q1
$20.3M Buy
65,789
+32,867
+100% +$10.1M ﹤0.01% 1170
2024
Q4
$11.6M Sell
32,922
-2,666
-7% -$941K ﹤0.01% 1487
2024
Q3
$12.8M Buy
35,588
+759
+2% +$272K ﹤0.01% 1436
2024
Q2
$11.1M Sell
34,829
-5,557
-14% -$1.77M ﹤0.01% 1455
2024
Q1
$9.28M Buy
40,386
+8,963
+29% +$2.06M ﹤0.01% 1538
2023
Q4
$6.91M Buy
31,423
+17,881
+132% +$3.93M ﹤0.01% 1717
2023
Q3
$3.06M Buy
13,542
+2,815
+26% +$636K ﹤0.01% 2155
2023
Q2
$2.37M Buy
10,727
+1,515
+16% +$334K ﹤0.01% 2385
2023
Q1
$2.06M Sell
9,212
-6,578
-42% -$1.47M ﹤0.01% 2476
2022
Q4
$4.39M Sell
15,790
-6,859
-30% -$1.91M ﹤0.01% 1947
2022
Q3
$4.74M Buy
22,649
+1,690
+8% +$354K ﹤0.01% 1831
2022
Q2
$4.94M Sell
20,959
-2,275
-10% -$536K ﹤0.01% 1840
2022
Q1
$4.17M Sell
23,234
-13,097
-36% -$2.35M ﹤0.01% 2089
2021
Q4
$7.85M Buy
36,331
+9,910
+38% +$2.14M ﹤0.01% 1758
2021
Q3
$4.88M Buy
26,421
+3,279
+14% +$605K ﹤0.01% 2009
2021
Q2
$4.15M Buy
23,142
+4,176
+22% +$749K ﹤0.01% 2152
2021
Q1
$3.17M Sell
18,966
-702
-4% -$117K ﹤0.01% 2293
2020
Q4
$2.99M Sell
19,668
-4,580
-19% -$695K ﹤0.01% 2216
2020
Q3
$2.45M Buy
24,248
+7,865
+48% +$794K ﹤0.01% 2187
2020
Q2
$1.98M Sell
16,383
-1,391
-8% -$168K ﹤0.01% 2284
2020
Q1
$1.69M Sell
17,774
-1,501
-8% -$142K ﹤0.01% 2263
2019
Q4
$1.7M Sell
19,275
-5,082
-21% -$448K ﹤0.01% 2530
2019
Q3
$1.94M Sell
24,357
-11,758
-33% -$938K ﹤0.01% 2347
2019
Q2
$2.82M Buy
36,115
+4,190
+13% +$327K ﹤0.01% 2108
2019
Q1
$3.75M Sell
31,925
-8,750
-22% -$1.03M ﹤0.01% 1886
2018
Q4
$4.43M Sell
40,675
-21,954
-35% -$2.39M ﹤0.01% 1714
2018
Q3
$7.97M Buy
62,629
+11,599
+23% +$1.48M ﹤0.01% 1476
2018
Q2
$5.77M Sell
51,030
-66,411
-57% -$7.51M ﹤0.01% 1592
2018
Q1
$13.2M Sell
117,441
-102,676
-47% -$11.5M 0.01% 1149
2017
Q4
$32.6M Sell
220,117
-8,172
-4% -$1.21M 0.01% 689
2017
Q3
$26.8M Buy
228,289
+165,234
+262% +$19.4M 0.01% 769
2017
Q2
$8.18M Buy
63,055
+31,776
+102% +$4.12M ﹤0.01% 1348
2017
Q1
$4.24M Sell
31,279
-2,610
-8% -$353K ﹤0.01% 1675
2016
Q4
$4.86M Buy
33,889
+4,373
+15% +$627K ﹤0.01% 1574
2016
Q3
$3.49M Sell
29,516
-62,766
-68% -$7.41M ﹤0.01% 1728
2016
Q2
$9.77M Sell
92,282
-17,689
-16% -$1.87M 0.01% 1222
2016
Q1
$12.3M Buy
109,971
+39,964
+57% +$4.45M 0.01% 1081
2015
Q4
$11M Sell
70,007
-3,932
-5% -$616K 0.01% 1169
2015
Q3
$9.7M Buy
73,939
+45,625
+161% +$5.99M 0.01% 979
2015
Q2
$4.93M Sell
28,314
-12,859
-31% -$2.24M ﹤0.01% 1372
2015
Q1
$7.1M Sell
41,173
-21,799
-35% -$3.76M 0.01% 1186
2014
Q4
$8.15M Sell
62,972
-8,925
-12% -$1.16M 0.01% 1112
2014
Q3
$9.25M Sell
71,897
-38,294
-35% -$4.93M 0.01% 1046
2014
Q2
$9.75M Buy
110,191
+14,927
+16% +$1.32M 0.01% 1059
2014
Q1
$8.96M Buy
95,264
+4,139
+5% +$389K 0.01% 1060
2013
Q4
$10.3M Sell
91,125
-84,194
-48% -$9.52M 0.01% 953
2013
Q3
$13.8M Buy
175,319
+17,354
+11% +$1.37M 0.01% 770
2013
Q2
$10.4M Buy
+157,965
New +$10.4M 0.01% 829